We hypothesized two possibilities: one was that PD-L1+MDSCs that increased in the tumor microenvironment migrated to the peripheral blood, and the other was that PD-L1+MDSCs were generated in the peripheral blood of patients with HCCs. The gene discussed is CD274; the disease is neoplasm.